Al Swaff, Reham

drrehamalswaff@med.asu.edu.eg
Internal ID: rp05604
Network Lab View Statistics Email Alert RSS Feed

Profile

Email
drrehamalswaff@med.asu.edu.eg
 
Loading... 2 0 20 0 false
 
Full Name
Al Swaff, Reham
 

Publications


Refined By:
Fulltext:  With Fulltext
Type:  Article

Results 1-13 of 13 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
12018• Impact of Diabetic Control on Achieving Sustained Virologic Response in Chronic HCV Patients Receiving Direct-Acting AntiviralsAl Swaff, Reham 
2Apr-2017• Circulating Leptin in Patients with Liver Cirrhosis and Hepatocellular CarcinomaAl Swaff, Reham 
32017•The Association between Systemic Hypertension and Chronic HCV-4 InfectionAl Swaff, Reham 
4Oct-2016• Prediction of Post-operative Mortality in Patients with HCV-related Cirrhosis Undergoing Non-Hepatic SurgeriesAl Swaff, Reham 
52014Cardiac Output Changes in Hepatorenal SyndromeAl Swaff, Reham 
62014• Prevalence of Eosinophilic Esophagitis in Patients with Refractory Gastro-esophageal Reflux Disease SymptomsAl Swaff, Reham 
72013• Effect of Prolongation of Combined Treatment in HCV-4 InfectionAl Swaff, Reham 
82012• Virologic response at week 8 of combined treatment as a predictor of SVR in non RVR, Chronic HCV Genotype 4 infected patientsAl Swaff, Reham 
92012• Correlation between Alanine Aminotransferase level, HCV RNA titer and fibrosis stage in chronic HCV genotype 4 infectionAl Swaff, Reham 
102012• Effect of Well Controlled Diabetes Mellitus on Sustained Virologic Response in Chronic HCV Genotype 4 Infected PatientsAl Swaff, Reham 
112012• Correlation between level of Viremia and Insulin Resistance in Patients with Chronic Hepatitis C virus genotype 4 InfectionAl Swaff, Reham 
12Aug-2011• The prevalence of occult hepatitis B infection among hepatitis C virus genotype 4 chronically infected Egyptian patients and its effect on response to combined therapy (pegylated interferon alpha 2 a and ribavirin ) for HCV chronic infectionAl Swaff, Reham 
13Sep-2008• Assessment of ascitic fluid complement 3 level in cirrhotic patients with and without spontaneous bacterial peritonitisAl Swaff, Reham